125 related articles for article (PubMed ID: 25374086)
1. [Semi-quantitative detection of HPV L1 capsid protein in exfoliative cytological examination facilitates the differential diagnosis of cervical lesions].
Xu X; Yang J; Lin N; Yang G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1194-7. PubMed ID: 25374086
[TBL] [Abstract][Full Text] [Related]
2. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
[No Abstract] [Full Text] [Related]
3. Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology.
Lee SJ; Lee AW; Kang CS; Park JS; Park DC; Ki EY; Lee KH; Yoon JH; Hur SY; Kim TJ
Int J Med Sci; 2014; 11(1):80-6. PubMed ID: 24396289
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus DNA, HPV L1 capsid protein and p16
Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.
Yemelyanova A; Gravitt PE; Ronnett BM; Rositch AF; Ogurtsova A; Seidman J; Roden RB
Mod Pathol; 2013 Feb; 26(2):268-74. PubMed ID: 22996373
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of HPV L1 capsid protein detection in cervical exfoliated cells in high-risk HPV positive women].
Wang J; Tian Q; Zhang S; Lyu L; Dong J; Lyu W
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):253-7. PubMed ID: 26080935
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical analysis of human papillomavirus L1 capsid protein in liquid-based cytology samples from cervical lesions.
Xiao W; Bian M; Ma L; Liu J; Chen Y; Yang B; Wu Q
Acta Cytol; 2010; 54(5):661-7. PubMed ID: 20968152
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions.
Balan R; Simion N; Giuşcă SE; Grigoraş A; Gheucă-Solovăstru L; Gheorghiţă V; Amălinei C; Căruntu ID
Rom J Morphol Embryol; 2011; 52(4):1187-94. PubMed ID: 22203921
[TBL] [Abstract][Full Text] [Related]
10. [Detection of human papillomavirus L1 capsid protein expression in liquid-based cytology samples with abnormal cytology.].
Xiao W; Bian ML; Ma L; Liu J; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):887-91. PubMed ID: 20193413
[TBL] [Abstract][Full Text] [Related]
11. Correlation between immunocytochemistry of human papilloma virus L1 capsid protein and behavior of low-grade cervical cytology in Korean women.
Lee SJ; Lee AW; Kim TJ; Kim JH; Bae JH; Lee CW; Song MJ; Yoon JH; Hur SY; Park JS
J Obstet Gynaecol Res; 2011 Sep; 37(9):1222-8. PubMed ID: 21518134
[TBL] [Abstract][Full Text] [Related]
12. HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions.
Mehlhorn G; Hautmann SK; Koch MC; Strehl JD; Hartmann A; Hilfrich R; Beckmann MW; Griesser H
Anticancer Res; 2014 Sep; 34(9):5127-32. PubMed ID: 25202103
[TBL] [Abstract][Full Text] [Related]
13. High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV-positive women with minor cytological abnormalities.
Norman I; Hjerpe A; Andersson S
Oncol Rep; 2013 Aug; 30(2):695-700. PubMed ID: 23756570
[TBL] [Abstract][Full Text] [Related]
14. E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma.
Choi YJ; Lee A; Kim TJ; Jin HT; Seo YB; Park JS; Lee SJ
J Gynecol Oncol; 2018 May; 29(3):e38. PubMed ID: 29400024
[TBL] [Abstract][Full Text] [Related]
15. The application of human papilloma virus genotyping for the identification of neoplasm lesions in the cervix of women with abnormal cytology smears.
Ciszek B; Heimrath J; Ciszek M
Adv Clin Exp Med; 2012; 21(6):759-66. PubMed ID: 23457134
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
Cao L; Sun PL; Yao M; Chen S; Gao H
Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
[TBL] [Abstract][Full Text] [Related]
17. HPV L1 capsid protein expression in squamous intraepithelial lesions of cervix uteri and its relevance to disease outcome.
Sarmadi S; Izadi-mood N; Pourlashkari M; Yarandi F; Sanii S
Arch Gynecol Obstet; 2012 Mar; 285(3):779-84. PubMed ID: 21789516
[TBL] [Abstract][Full Text] [Related]
18. A proper triage for detecting women with high-risk human papillomavirus genotypes other than HPV16/18.
Wang JJ; Lyu LP; Hu QW; Wan ZQ; Dong J; Pan M; Shen WW; Zhang S
Eur J Obstet Gynecol Reprod Biol; 2017 Dec; 219():113-118. PubMed ID: 29101837
[TBL] [Abstract][Full Text] [Related]
19. HPV L1 detection discriminates cervical precancer from transient HPV infection: a prospective international multicenter study.
Mehlhorn G; Obermann E; Negri G; Bubendorf L; Mian C; Koch M; Sander H; Simm B; Lütge M; Bánrévi Z; Weiss A; Cathomas G; Hilfrich R; Wilhelm Beckmann M; Griesser H
Mod Pathol; 2013 Jul; 26(7):967-74. PubMed ID: 23411486
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA.
Melsheimer P; Kaul S; Dobeck S; Bastert G
Acta Cytol; 2003; 47(2):124-8. PubMed ID: 12685176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
